Most Australians Declined H1N1 Shots, Say They Will Do So Again
This article was originally published in PharmAsia News
Not only did a majority of Australians decline shots against the H1N1 virus this past year, a similar number said they would do so again before the next Aussie winter
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.